BIIB: Biogen Inc. Stock

by  •  • Comments Off on BIIB: Biogen Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 16,875.57
Enterprise Value ($M) 20,796.37
Book Value ($M) 16,716.00
Book Value / Share 114.20
Price / Book 1.01
NCAV ($M) -3,876.50
NCAV / Share -26.48
Price / NCAV -4.35

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.11

Liquidity (mrq)
Quick Ratio 0.90
Current Ratio 1.35

Balance Sheet (mrq) ($M)
Current Assets 7,456.80
Assets 28,049.30
Liabilities 11,333.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 9,675.90
Operating Income 2,344.20
Net Income 1,632.20
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 2,875.50
Cash from Investing -799.20
Cash from Financing -683.50

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2 days ago 13G/A BlackRock, Inc. 8.50 -14.61
11-12 13G/A Vanguard Group Inc 11.44 0.00
10-16 13G State Street Corp 5.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-24 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 248,698 889,253 27.97
2025-04-16 291,796 1,018,467 28.65
2025-04-15 169,900 807,341 21.04
2025-04-14 356,482 1,194,105 29.85

(click for more detail)

Similar Companies
BCRX – BioCryst Pharmaceuticals, Inc. BDTX – Black Diamond Therapeutics, Inc.
BEAM – Beam Therapeutics Inc. BLUE – bluebird bio, Inc.
BMEA – Biomea Fusion, Inc.


Financial data and stock pages provided by
Fintel.io